America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...
Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...
FDA review confirmed overall safety of 16 brands of baby formula. In a STAT Q&A, experts unpack what low-level PFAS findings ...
Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent ...
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical ...
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...
Elevance Health is blocking the deposition of Peter Haytaian, an outgoing executive who previously oversaw the health insurer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results